Terms: = Thyroid cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
487 results:
1. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
[TBL] [Abstract] [Full Text] [Related]
3. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
4. Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival.
Yang L; Murthy S; Cortellini A; Lim EA; Gonzalez M; Pinato DJ; Abdel-Malek M; Mahmoud S; Martin NM
Front Endocrinol (Lausanne); 2024; 15():1369268. PubMed ID: 38681767
[TBL] [Abstract] [Full Text] [Related]
5. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract] [Full Text] [Related]
6. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
7. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
[TBL] [Abstract] [Full Text] [Related]
8. [Importance of Secondary cancer Screening-In the Case of Childhood cancer].
Ishida Y
Gan To Kagaku Ryoho; 2024 Feb; 51(2):119-124. PubMed ID: 38449394
[TBL] [Abstract] [Full Text] [Related]
9. Two Hematological Markers Predicting the Efficacy and prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast cancer.
Wang C; Shi Q; Zhang G; Wu X; Yan W; Wan A; Xiong S; Yuan L; Tian H; Ma D; Jiang J; Qi X; Zhang Y
Oncologist; 2024 May; 29(5):e635-e642. PubMed ID: 38431781
[TBL] [Abstract] [Full Text] [Related]
10. [Not Available].
Mensi S; Ezzine A; Dardouri T; Ben Rejeb M; Ben Fredj M; Chatti K
Tunis Med; 2023 May; 101(5):521-526. PubMed ID: 38372523
[TBL] [Abstract] [Full Text] [Related]
11. Tyrosine kinase inhibitors for radioiodine refractory differentiated thyroid cancer: A systematic review and meta-analysis.
Yu J; Liu Z; Su Y; Peng X; Xie Y
Clin Endocrinol (Oxf); 2024 Apr; 100(4):379-388. PubMed ID: 38351437
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of airway stenting and nasogastric tube insertion in airway-esophageal fistula patients with airways compromised by advanced malignancy.
Wu X; Lu G; Luo LC; Wei H; Yi Q; Luo W
Clin Respir J; 2024 Feb; 18(2):e13737. PubMed ID: 38350674
[TBL] [Abstract] [Full Text] [Related]
13. Pregnancy and the disease recurrence of patients previously treated for differentiated thyroid cancer: A systematic review and meta analysis.
Shan R; Li X; Tao M; Xiao W; Chen J; Mei F; Song S; Sun B; Yuan C; Liu Z
Chin Med J (Engl); 2024 Mar; 137(5):547-555. PubMed ID: 38311812
[TBL] [Abstract] [Full Text] [Related]
14. Intraventricular Cerebral Metastases: A Comprehensive Systematic Review.
Scalia G; Silven MP; Costanzo R; Porzio M; Maugeri R; Iacopino DG; Nicoletti GF; Umana GE
Anticancer Res; 2024 Feb; 44(2):453-462. PubMed ID: 38307552
[TBL] [Abstract] [Full Text] [Related]
15. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
Fukuda N; Toda K; Suto H; Oki R; Wang X; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
Endocr J; 2024 Apr; 71(4):363-371. PubMed ID: 38296547
[TBL] [Abstract] [Full Text] [Related]
16. Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors.
Wang J; Ma Y; Lin H; Wang J; Cao B
BMC Immunol; 2024 Jan; 25(1):8. PubMed ID: 38267897
[TBL] [Abstract] [Full Text] [Related]
17. Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features.
Tondi Resta I; Gubbiotti MA; Montone KT; Livolsi VA; Baloch ZW
Hum Pathol; 2024 Feb; 144():53-60. PubMed ID: 38244615
[TBL] [Abstract] [Full Text] [Related]
18. Expression of
Soboska K; Kusiński M; Pawelczyk K; Migdalska-Sęk M; Brzeziańska-Lasota E; Czarnecka-Chrebelska KH
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203733
[TBL] [Abstract] [Full Text] [Related]
19. Survival Outcomes of Medullary thyroid cancer With and Without Amyloid Deposition.
Toraih E; Hussein M; Anker A; Baah S; Pinion D; Jishu J; Sadakkadulla S; Case M; LaForteza A; Moroz K; Kandil E
Endocr Pract; 2024 Apr; 30(4):311-318. PubMed ID: 38184237
[TBL] [Abstract] [Full Text] [Related]
20. ER+/PR- phenotype exhibits more aggressive biological features and worse outcome compared with ER+/PR+ phenotype in HER2-negative inflammatory breast cancer.
Luo Y; Li Q; Fang J; Pan C; Zhang L; Xu X; Qian S; Zhao X; Hou L
Sci Rep; 2024 Jan; 14(1):197. PubMed ID: 38167641
[TBL] [Abstract] [Full Text] [Related]
[Next]
